| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |